| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Associations of obesity with co-morbidities in early adult life
|
Sørensen, Thorkild I A
|
|
|
13 |
2 |
p. 77-78
|
artikel
|
| 2 |
Bariatric surgery in children with obesity and type 2 diabetes
|
Desai, Ashish P
|
|
|
13 |
2 |
p. 86
|
artikel
|
| 3 |
Barriers to care for refugees and migrants with diabetes
|
Jobanputra, Kiran
|
|
|
13 |
2 |
p. 83-85
|
artikel
|
| 4 |
Correction to Lancet Diabetes Endocrinol 2024; 12: 619–30
|
|
|
|
13 |
2 |
p. e2
|
artikel
|
| 5 |
Dissection of type 2 diabetes: a genetic perspective
|
Bonnefond, Amélie
|
|
|
13 |
2 |
p. 149-164
|
artikel
|
| 6 |
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
|
Butt, Jawad H
|
|
|
13 |
2 |
p. 107-118
|
artikel
|
| 7 |
Food for thought
|
Burki, Talha
|
|
|
13 |
2 |
p. 87
|
artikel
|
| 8 |
Halving heart failure outcomes by finerenone-mediated type 2 diabetes prevention
|
Gerstein, Hertzel C
|
|
|
13 |
2 |
p. 78-79
|
artikel
|
| 9 |
Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2–20 years) with type 1 diabetes: a population-based study
|
Karges, Beate
|
|
|
13 |
2 |
p. 88-96
|
artikel
|
| 10 |
Innovations in diabetic retinopathy screening in the UK
|
Sivaprasad, Sobha
|
|
|
13 |
2 |
p. 81-83
|
artikel
|
| 11 |
Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
|
Stefan, Norbert
|
|
|
13 |
2 |
p. 134-148
|
artikel
|
| 12 |
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort
|
Yang, Jun
|
|
|
13 |
2 |
p. 119-133
|
artikel
|
| 13 |
Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study
|
Zloof, Yair
|
|
|
13 |
2 |
p. 97-106
|
artikel
|
| 14 |
Rating the response of primary aldosteronism to targeted medical treatment with the PAMO criteria
|
Steichen, Olivier
|
|
|
13 |
2 |
p. 80-81
|
artikel
|
| 15 |
Redefining obesity: advancing care for better lives
|
The Lancet Diabetes & Endocrinology,
|
|
|
13 |
2 |
p. 75
|
artikel
|
| 16 |
Technology for type 1 diabetes: what impact will it have?
|
Craig, Maria E
|
|
|
13 |
2 |
p. 76-77
|
artikel
|
Tijdschrift beschrijving